MADRIGAL PHARMACEUTICALS Director Sells Shares Worth Over $13 Million
Paul A. Friedman, a director and 10% owner of Madrigal Pharmaceuticals, sold 24,800 shares for $13,694,157 on December 10, 2025. The sales were part of a Rule 10b5-1 trading plan adopted in September 2025. Post-sale, Friedman holds 187,164 shares directly and 655,540 shares indirectly through SQN LLC.
TradingView·